Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017
- PMID: 37095610
- PMCID: PMC10323082
- DOI: 10.1111/cas.15823
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017
Abstract
Skin cancer is most frequently diagnosed in the White population. However, its subtypes and epidemiology in Japan are understudied. We aimed to elucidate skin cancer incidence in Japan based on the National Cancer Registry, a new nationwide integrated population-based registry. Data from patients diagnosed with skin cancer in 2016 and 2017 were extracted and classified by cancer subtypes. Data were analyzed using the World Health Organization and General Rules tumor classifications. Tumor incidence was calculated as the number of new cases divided by the corresponding total person-years. Overall, 67,867 patients with skin cancer were included. The percentage of each subtype was as follows: basal cell carcinoma, 37.2%; squamous cell carcinoma, 43.9% (18.3% of which, in situ); malignant melanoma, 7.2% (22.1% of which, in situ); extramammary Paget's disease, 3.1% (24.9% of which, in situ); adnexal carcinoma, 2.9%; dermatofibrosarcoma protuberans, 0.9%; Merkel cell carcinoma, 0.6%; angiosarcoma, 0.5%; and hematologic malignancies, 3.8%. The overall age-adjusted incidence of skin cancer was 27.89 for the Japanese population model and 9.28 for the World Health Organization (WHO) model. The incidences of basal cell carcinoma and squamous cell carcinoma were the highest (3.63 and 3.40 per 100,000 persons, respectively, in the WHO model) among skin cancers, whereas the incidences of angiosarcoma and Merkel cell carcinoma were the lowest (0.026 and 0.038 per 100,000 persons, respectively, in the WHO model). This is the first report to provide comprehensive information on the epidemiological status of skin cancers in Japan using population-based NCR data.
Keywords: basal cell carcinoma; epidemiology; incidence rate; skin cancer; squamous cell carcinoma.
© 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Conflict of interest statement
The authors have no conflict of interest.
Figures



Similar articles
-
Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.J Dermatol. 2024 Apr;51(4):532-538. doi: 10.1111/1346-8138.17118. Epub 2024 Feb 17. J Dermatol. 2024. PMID: 38366757
-
Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands.Br J Dermatol. 2025 May 19;192(6):1029-1037. doi: 10.1093/bjd/ljaf027. Br J Dermatol. 2025. PMID: 39854282
-
Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study.Cancer Epidemiol. 2016 Dec;45:6-10. doi: 10.1016/j.canep.2016.09.001. Epub 2016 Sep 14. Cancer Epidemiol. 2016. PMID: 27639035
-
Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer Registry, 2016-2017.Int J Clin Oncol. 2025 Feb;30(2):194-198. doi: 10.1007/s10147-024-02675-0. Epub 2025 Jan 3. Int J Clin Oncol. 2025. PMID: 39751752 Review.
-
Epidemiology of skin cancer in the mature patient.Clin Dermatol. 2018 Mar-Apr;36(2):167-176. doi: 10.1016/j.clindermatol.2017.10.008. Epub 2017 Oct 13. Clin Dermatol. 2018. PMID: 29566921 Review.
Cited by
-
A 37-Year Retrospective Analysis Reveals a High Rate of Cutaneous Angiosarcoma of the Scalp in Okinawa, Japan.Cancer Sci. 2025 Apr;116(4):1059-1067. doi: 10.1111/cas.16453. Epub 2025 Jan 16. Cancer Sci. 2025. PMID: 39822133 Free PMC article.
-
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.Int J Hematol. 2025 Feb;121(2):161-173. doi: 10.1007/s12185-024-03875-0. Epub 2024 Nov 26. Int J Hematol. 2025. PMID: 39586984 Free PMC article.
-
Improvements in the prognosis of patients with stage IV renal cancer according to the era of therapeutic agents: an analysis of National Cancer Registry data.Transl Androl Urol. 2025 Jun 30;14(6):1734-1741. doi: 10.21037/tau-2025-163. Epub 2025 Jun 26. Transl Androl Urol. 2025. PMID: 40687664 Free PMC article.
-
Indocyanine Green Fluorescence Imaging in the Surgical Management of Skin Squamous Cell Carcinoma.Clin Cosmet Investig Dermatol. 2023 Nov 15;16:3309-3320. doi: 10.2147/CCID.S413266. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 38021421 Free PMC article.
-
Gene-Environment Interaction: Small Deletions (DELs) and Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) and Potential Implications for Therapy.Cells. 2025 Jan 10;14(2):95. doi: 10.3390/cells14020095. Cells. 2025. PMID: 39851523 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures . 2003. Accessed January 5, 2023. http://adph.org/ascr/assets/AlaCancerFactsFigures2003.pdf
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical